Global LNP-mRNA Therapy market size is predicted to grow from US$ 541 million in 2025 to US$ 797 million in 2032; it is expected to grow at a CAGR of 5.8% from 2026 to 2032.

Global LNP-mRNA Therapy Market Size, Share and Analysis 2026-32

The global LNP-mRNA Therapy market size is predicted to grow from US$ 541 million in 2025 to US$ 797 million in 2032; it is expected to grow at a CAGR of 5.8% from 2026 to 2032. LNP-mRNA Therapy represents a cutting-edge biomedical technology that leverages the unique strengths of Lipid Nanoparticles (LNPs) and Messenger RNA (mRNA) to offer novel treatment avenues for various diseases. Serving as carriers, LNPs effectively shield mRNA from enzymatic degradation in the body and deliver it precisely to target cells. mRNA carries the genetic information necessary for synthesizing specific proteins; once inside cells, it directs the cells to produce these proteins, thereby triggering immune responses or repairing damaged tissues. This therapy demonstrates significant potential in treating cancers, genetic disorders, and infectious diseases. Its highly personalized and rapid-response characteristics have made LNP-mRNA Therapy a research focus in the biomedical field. By precisely regulating gene expression, LNP-mRNA Therapy provides patients with unprecedented treatment options, ushering in a new era of precision medicine. The LNP-mRNA Therapy market is in a phase of rapid development. Following the successful application of COVID-19 vaccines, global R&D focus has expanded to areas such as cancer immunotherapy, rare genetic diseases, cardiovascular diseases, and regenerative medicine. With the optimization of intelligent delivery systems and the maturation of production processes, the market size is expected to maintain high growth over the next decade, driven by the needs of infectious disease control, large-scale data center-based vaccine production capabilities, investment in new energy medical technologies, and the trend towards precision medicine. Despite challenges such as cost, stability, and regulation, with policy support and capital investment in North America, Europe, and the Asia-Pacific region, LNP-mRNA technology is poised to become a core platform for next-generation biomedicine, driving the upgrading of the global pharmaceutical industry structure. Infinity Market Research newest research report, the LNP-mRNA Therapy Industry Forecast looks at past sales and reviews total world LNP-mRNA Therapy sales in 2025, providing a comprehensive analysis by region and market sector of projected LNP-mRNA Therapy sales for 2026 through 2032. With LNP-mRNA Therapy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world LNP-mRNA Therapy industry. This Insight Report provides a comprehensive analysis of the global LNP-mRNA Therapy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on LNP-mRNA Therapy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms unique position in an accelerating global LNP-mRNA Therapy market. This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for LNP-mRNA Therapy and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global LNP-mRNA Therapy. This report presents a comprehensive overview, market shares, and growth opportunities of LNP-mRNA Therapy market by product type, application, key players and key regions and countries. Segmentation by Type: &nbsp;&nbsp;&nbsp; Passive Targeting &nbsp;&nbsp;&nbsp; Active Targeting &nbsp;&nbsp;&nbsp; Segmentation by Treatment Direction: &nbsp;&nbsp;&nbsp; Vaccines &nbsp;&nbsp;&nbsp; Cancer Immunotherapy &nbsp;&nbsp;&nbsp; Genetic Disease Therapy &nbsp;&nbsp;&nbsp; Others &nbsp;&nbsp;&nbsp; Segmentation by Mechanisms of Action: &nbsp;&nbsp;&nbsp; Protein Replacement Therapy &nbsp;&nbsp;&nbsp; Immune Activation Therapy &nbsp;&nbsp;&nbsp; Gene Regulation Therapy Segmentation by Application: &nbsp;&nbsp;&nbsp; Hospital &nbsp;&nbsp;&nbsp; Clinic &nbsp;&nbsp;&nbsp; Others This report also splits the market by region: &nbsp;&nbsp;&nbsp; Americas &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; United States &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Canada &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mexico &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Brazil &nbsp;&nbsp;&nbsp; APAC &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; China &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Japan &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Korea &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Southeast Asia &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; India &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Australia &nbsp;&nbsp;&nbsp; Europe &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Germany &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; France &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; UK &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Italy &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Russia &nbsp;&nbsp;&nbsp; Middle East & Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Egypt &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; South Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Israel &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Turkey &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; GCC Countries The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the companys coverage, product portfolio, its market penetration. &nbsp;&nbsp;&nbsp; Genevant Sciences &nbsp;&nbsp;&nbsp; Moderna &nbsp;&nbsp;&nbsp; BioNTech &nbsp;&nbsp;&nbsp; Pfizer &nbsp;&nbsp;&nbsp; NanoVation Therapeutics &nbsp;&nbsp;&nbsp; CureVac &nbsp;&nbsp;&nbsp; Sanofi &nbsp;&nbsp;&nbsp; Promab &nbsp;&nbsp;&nbsp; Grand Pharm &nbsp;&nbsp;&nbsp; Arcturus Therapeutics &nbsp;&nbsp;&nbsp; Synplogen &nbsp;&nbsp;&nbsp; CSPC &nbsp;&nbsp;&nbsp; Beijing JenKem Technology &nbsp;&nbsp;&nbsp; Starna Therapeutics

1 Scope of the Report &nbsp;1.1 Market Introduction &nbsp;1.2 Years Considered &nbsp;1.3 Research Objectives &nbsp;1.4 Market Research Methodology &nbsp;1.5 Research Process and Data Source &nbsp;1.6 Economic Indicators &nbsp;1.7 Currency Considered &nbsp;1.8 Market Estimation Caveats 2 Executive Summary &nbsp;2.1 World Market Overview &nbsp;2.1.1 Global LNP-mRNA Therapy Market Size (2021-2032) &nbsp;2.1.2 LNP-mRNA Therapy Market Size CAGR by Region (2021 VS 2025 VS 2032) &nbsp;2.1.3 World Current & Future Analysis for LNP-mRNA Therapy by Country/Region (2021, 2025 & 2032) &nbsp;2.2 LNP-mRNA Therapy Segment by Type &nbsp;2.2.1 Passive Targeting &nbsp;2.2.2 Active Targeting &nbsp;2.2.3 LNP-mRNA Therapy Market Size by Type &nbsp;2.2.3.1 LNP-mRNA Therapy Market Size CAGR by Type (2021 VS 2025 VS 2032) &nbsp;2.2.3.2 Global LNP-mRNA Therapy Market Size Market Share by Type (2021-2026) &nbsp;2.3 LNP-mRNA Therapy Segment by Treatment Direction &nbsp;2.3.1 Vaccines &nbsp;2.3.2 Cancer Immunotherapy &nbsp;2.3.3 Genetic Disease Therapy &nbsp;2.3.4 Others &nbsp;2.3.5 LNP-mRNA Therapy Market Size by Treatment Direction &nbsp;2.3.5.1 LNP-mRNA Therapy Market Size CAGR by Treatment Direction (2021 VS 2025 VS 2032) &nbsp;2.3.5.2 Global LNP-mRNA Therapy Market Size Market Share by Treatment Direction (2021-2026) &nbsp;2.4 LNP-mRNA Therapy Segment by Mechanisms of Action &nbsp;2.4.1 Protein Replacement Therapy &nbsp;2.4.2 Immune Activation Therapy &nbsp;2.4.3 Gene Regulation Therapy &nbsp;2.4.4 LNP-mRNA Therapy Market Size by Mechanisms of Action &nbsp;2.4.4.1 LNP-mRNA Therapy Market Size CAGR by Mechanisms of Action (2021 VS 2025 VS 2032) &nbsp;2.4.4.2 Global LNP-mRNA Therapy Market Size Market Share by Mechanisms of Action (2021-2026) &nbsp;2.5 LNP-mRNA Therapy Segment by Application &nbsp;2.5.1 Hospital &nbsp;2.5.2 Clinic &nbsp;2.5.3 Others &nbsp;2.5.4 LNP-mRNA Therapy Market Size by Application &nbsp;2.5.4.1 LNP-mRNA Therapy Market Size CAGR by Application (2021 VS 2025 VS 2032) &nbsp;2.5.4.2 Global LNP-mRNA Therapy Market Size Market Share by Application (2021-2026) 3 LNP-mRNA Therapy Market Size by Player &nbsp;3.1 LNP-mRNA Therapy Market Size Market Share by Player &nbsp;3.1.1 Global LNP-mRNA Therapy Revenue by Player (2021-2026) &nbsp;3.1.2 Global LNP-mRNA Therapy Revenue Market Share by Player (2021-2026) &nbsp;3.2 Global LNP-mRNA Therapy Key Players Head office and Products Offered &nbsp;3.3 Market Concentration Rate Analysis &nbsp;3.3.1 Competition Landscape Analysis &nbsp;3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026) &nbsp;3.4 New Products and Potential Entrants &nbsp;3.5 Mergers & Acquisitions, Expansion 4 LNP-mRNA Therapy by Region &nbsp;4.1 LNP-mRNA Therapy Market Size by Region (2021-2026) &nbsp;4.2 Global LNP-mRNA Therapy Annual Revenue by Country/Region (2021-2026) &nbsp;4.3 Americas LNP-mRNA Therapy Market Size Growth (2021-2026) &nbsp;4.4 APAC LNP-mRNA Therapy Market Size Growth (2021-2026) &nbsp;4.5 Europe LNP-mRNA Therapy Market Size Growth (2021-2026) &nbsp;4.6 Middle East & Africa LNP-mRNA Therapy Market Size Growth (2021-2026) 5 Americas &nbsp;5.1 Americas LNP-mRNA Therapy Market Size by Country (2021-2026) &nbsp;5.2 Americas LNP-mRNA Therapy Market Size by Type (2021-2026) &nbsp;5.3 Americas LNP-mRNA Therapy Market Size by Application (2021-2026) &nbsp;5.4 United States &nbsp;5.5 Canada &nbsp;5.6 Mexico &nbsp;5.7 Brazil 6 APAC &nbsp;6.1 APAC LNP-mRNA Therapy Market Size by Region (2021-2026) &nbsp;6.2 APAC LNP-mRNA Therapy Market Size by Type (2021-2026) &nbsp;6.3 APAC LNP-mRNA Therapy Market Size by Application (2021-2026) &nbsp;6.4 China &nbsp;6.5 Japan &nbsp;6.6 South Korea &nbsp;6.7 Southeast Asia &nbsp;6.8 India &nbsp;6.9 Australia 7 Europe &nbsp;7.1 Europe LNP-mRNA Therapy Market Size by Country (2021-2026) &nbsp;7.2 Europe LNP-mRNA Therapy Market Size by Type (2021-2026) &nbsp;7.3 Europe LNP-mRNA Therapy Market Size by Application (2021-2026) &nbsp;7.4 Germany &nbsp;7.5 France &nbsp;7.6 UK &nbsp;7.7 Italy &nbsp;7.8 Russia 8 Middle East & Africa &nbsp;8.1 Middle East & Africa LNP-mRNA Therapy by Region (2021-2026) &nbsp;8.2 Middle East & Africa LNP-mRNA Therapy Market Size by Type (2021-2026) &nbsp;8.3 Middle East & Africa LNP-mRNA Therapy Market Size by Application (2021-2026) &nbsp;8.4 Egypt &nbsp;8.5 South Africa &nbsp;8.6 Israel &nbsp;8.7 Turkey &nbsp;8.8 GCC Countries 9 Market Drivers, Challenges and Trends &nbsp;9.1 Market Drivers & Growth Opportunities &nbsp;9.2 Market Challenges & Risks &nbsp;9.3 Industry Trends 10 Global LNP-mRNA Therapy Market Forecast &nbsp;10.1 Global LNP-mRNA Therapy Forecast by Region (2027-2032) &nbsp;10.1.1 Global LNP-mRNA Therapy Forecast by Region (2027-2032) &nbsp;10.1.2 Americas LNP-mRNA Therapy Forecast &nbsp;10.1.3 APAC LNP-mRNA Therapy Forecast &nbsp;10.1.4 Europe LNP-mRNA Therapy Forecast &nbsp;10.1.5 Middle East & Africa LNP-mRNA Therapy Forecast &nbsp;10.2 Americas LNP-mRNA Therapy Forecast by Country (2027-2032) &nbsp;10.2.1 United States Market LNP-mRNA Therapy Forecast &nbsp;10.2.2 Canada Market LNP-mRNA Therapy Forecast &nbsp;10.2.3 Mexico Market LNP-mRNA Therapy Forecast &nbsp;10.2.4 Brazil Market LNP-mRNA Therapy Forecast &nbsp;10.3 APAC LNP-mRNA Therapy Forecast by Region (2027-2032) &nbsp;10.3.1 China LNP-mRNA Therapy Market Forecast &nbsp;10.3.2 Japan Market LNP-mRNA Therapy Forecast &nbsp;10.3.3 Korea Market LNP-mRNA Therapy Forecast &nbsp;10.3.4 Southeast Asia Market LNP-mRNA Therapy Forecast &nbsp;10.3.5 India Market LNP-mRNA Therapy Forecast &nbsp;10.3.6 Australia Market LNP-mRNA Therapy Forecast &nbsp;10.4 Europe LNP-mRNA Therapy Forecast by Country (2027-2032) &nbsp;10.4.1 Germany Market LNP-mRNA Therapy Forecast &nbsp;10.4.2 France Market LNP-mRNA Therapy Forecast &nbsp;10.4.3 UK Market LNP-mRNA Therapy Forecast &nbsp;10.4.4 Italy Market LNP-mRNA Therapy Forecast &nbsp;10.4.5 Russia Market LNP-mRNA Therapy Forecast &nbsp;10.5 Middle East & Africa LNP-mRNA Therapy Forecast by Region (2027-2032) &nbsp;10.5.1 Egypt Market LNP-mRNA Therapy Forecast &nbsp;10.5.2 South Africa Market LNP-mRNA Therapy Forecast &nbsp;10.5.3 Israel Market LNP-mRNA Therapy Forecast &nbsp;10.5.4 Turkey Market LNP-mRNA Therapy Forecast &nbsp;10.6 Global LNP-mRNA Therapy Forecast by Type (2027-2032) &nbsp;10.7 Global LNP-mRNA Therapy Forecast by Application (2027-2032) &nbsp;10.7.1 GCC Countries Market LNP-mRNA Therapy Forecast 11 Key Players Analysis &nbsp;11.1 Genevant Sciences &nbsp;11.1.1 Genevant Sciences Company Information &nbsp;11.1.2 Genevant Sciences LNP-mRNA Therapy Product Offered &nbsp;11.1.3 Genevant Sciences LNP-mRNA Therapy Revenue, Gross Margin and Market Share (2021-2026) &nbsp;11.1.4 Genevant Sciences Main Business Overview &nbsp;11.1.5 Genevant Sciences Latest Developments &nbsp;11.2 Moderna &nbsp;11.2.1 Moderna Company Information &nbsp;11.2.2 Moderna LNP-mRNA Therapy Product Offered &nbsp;11.2.3 Moderna LNP-mRNA Therapy Revenue, Gross Margin and Market Share (2021-2026) &nbsp;11.2.4 Moderna Main Business Overview &nbsp;11.2.5 Moderna Latest Developments &nbsp;11.3 BioNTech &nbsp;11.3.1 BioNTech Company Information &nbsp;11.3.2 BioNTech LNP-mRNA Therapy Product Offered &nbsp;11.3.3 BioNTech LNP-mRNA Therapy Revenue, Gross Margin and Market Share (2021-2026) &nbsp;11.3.4 BioNTech Main Business Overview &nbsp;11.3.5 BioNTech Latest Developments &nbsp;11.4 Pfizer &nbsp;11.4.1 Pfizer Company Information &nbsp;11.4.2 Pfizer LNP-mRNA Therapy Product Offered &nbsp;11.4.3 Pfizer LNP-mRNA Therapy Revenue, Gross Margin and Market Share (2021-2026) &nbsp;11.4.4 Pfizer Main Business Overview &nbsp;11.4.5 Pfizer Latest Developments &nbsp;11.5 NanoVation Therapeutics &nbsp;11.5.1 NanoVation Therapeutics Company Information &nbsp;11.5.2 NanoVation Therapeutics LNP-mRNA Therapy Product Offered &nbsp;11.5.3 NanoVation Therapeutics LNP-mRNA Therapy Revenue, Gross Margin and Market Share (2021-2026) &nbsp;11.5.4 NanoVation Therapeutics Main Business Overview &nbsp;11.5.5 NanoVation Therapeutics Latest Developments &nbsp;11.6 CureVac &nbsp;11.6.1 CureVac Company Information &nbsp;11.6.2 CureVac LNP-mRNA Therapy Product Offered &nbsp;11.6.3 CureVac LNP-mRNA Therapy Revenue, Gross Margin and Market Share (2021-2026) &nbsp;11.6.4 CureVac Main Business Overview &nbsp;11.6.5 CureVac Latest Developments &nbsp;11.7 Sanofi &nbsp;11.7.1 Sanofi Company Information &nbsp;11.7.2 Sanofi LNP-mRNA Therapy Product Offered &nbsp;11.7.3 Sanofi LNP-mRNA Therapy Revenue, Gross Margin and Market Share (2021-2026) &nbsp;11.7.4 Sanofi Main Business Overview &nbsp;11.7.5 Sanofi Latest Developments &nbsp;11.8 Promab &nbsp;11.8.1 Promab Company Information &nbsp;11.8.2 Promab LNP-mRNA Therapy Product Offered &nbsp;11.8.3 Promab LNP-mRNA Therapy Revenue, Gross Margin and Market Share (2021-2026) &nbsp;11.8.4 Promab Main Business Overview &nbsp;11.8.5 Promab Latest Developments &nbsp;11.9 Grand Pharm &nbsp;11.9.1 Grand Pharm Company Information &nbsp;11.9.2 Grand Pharm LNP-mRNA Therapy Product Offered &nbsp;11.9.3 Grand Pharm LNP-mRNA Therapy Revenue, Gross Margin and Market Share (2021-2026) &nbsp;11.9.4 Grand Pharm Main Business Overview &nbsp;11.9.5 Grand Pharm Latest Developments &nbsp;11.10 Arcturus Therapeutics &nbsp;11.10.1 Arcturus Therapeutics Company Information &nbsp;11.10.2 Arcturus Therapeutics LNP-mRNA Therapy Product Offered &nbsp;11.10.3 Arcturus Therapeutics LNP-mRNA Therapy Revenue, Gross Margin and Market Share (2021-2026) &nbsp;11.10.4 Arcturus Therapeutics Main Business Overview &nbsp;11.10.5 Arcturus Therapeutics Latest Developments &nbsp;11.11 Synplogen &nbsp;11.11.1 Synplogen Company Information &nbsp;11.11.2 Synplogen LNP-mRNA Therapy Product Offered &nbsp;11.11.3 Synplogen LNP-mRNA Therapy Revenue, Gross Margin and Market Share (2021-2026) &nbsp;11.11.4 Synplogen Main Business Overview &nbsp;11.11.5 Synplogen Latest Developments &nbsp;11.12 CSPC &nbsp;11.12.1 CSPC Company Information &nbsp;11.12.2 CSPC LNP-mRNA Therapy Product Offered &nbsp;11.12.3 CSPC LNP-mRNA Therapy Revenue, Gross Margin and Market Share (2021-2026) &nbsp;11.12.4 CSPC Main Business Overview &nbsp;11.12.5 CSPC Latest Developments &nbsp;11.13 Beijing JenKem Technology &nbsp;11.13.1 Beijing JenKem Technology Company Information &nbsp;11.13.2 Beijing JenKem Technology LNP-mRNA Therapy Product Offered &nbsp;11.13.3 Beijing JenKem Technology LNP-mRNA Therapy Revenue, Gross Margin and Market Share (2021-2026) &nbsp;11.13.4 Beijing JenKem Technology Main Business Overview &nbsp;11.13.5 Beijing JenKem Technology Latest Developments &nbsp;11.14 Starna Therapeutics &nbsp;11.14.1 Starna Therapeutics Company Information &nbsp;11.14.2 Starna Therapeutics LNP-mRNA Therapy Product Offered &nbsp;11.14.3 Starna Therapeutics LNP-mRNA Therapy Revenue, Gross Margin and Market Share (2021-2026) &nbsp;11.14.4 Starna Therapeutics Main Business Overview &nbsp;11.14.5 Starna Therapeutics Latest Developments 12 Research Findings and Conclusion

Report	Global LNP-mRNA Therapy Market Growth (Status and Outlook) 2026-2032
Selected License	Multi ID: ILR1764

Buyer Information

Order Summary